Thiogenesis Therapeutics, Corp. SEC filings TTIPF
Thiogenesis Therapeutics, Corp. has 5 filings in SEC EDGAR's recent list, going back to Aug 11, 2021. The company's fiscal year ends on February 28.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Jun 9, 2026 | — |
| D | Filing | Aug 8, 2025 | — |
| D | Filing | Dec 20, 2023 | — |
| D | Filing | Nov 25, 2022 | — |
| D | Filing | Aug 11, 2021 | — |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Listed as
- TTIPF (OTC)
- Fiscal year ends
- February 28
- Incorporated in
- Ontario, Canada
- Headquarters
- Toronto, Ontario, Canada
- SEC CIK
- 1877778
- Former names
- Rozdil Capital Corp (until Aug 11, 2021)
Source: SEC EDGAR filings. This is company-reported data, not investment advice.